NeoStem, Inc. , a leader in the emerging cellular therapy industry, announced today that it has entered into a Loan and Security Agreement with Oxford Finance LLC pursuant to which Oxford has agreed to make a term loan to the Company in the principal amount of up to $20 million, and has made the initial disbursement of $15 million. The loan matures in September 2018 and the additional $5 million disbursement is available in the event of the Company's consummation of a partnering transaction around the Company's NBS10 development program for post acute myocardial infarction patients.
http://ift.tt/10f2mj9
http://ift.tt/10f2mj9
No comments:
Post a Comment